IOL Chemicals and Pharmaceuticals cash flow

Latest FY26

Cash from operations: ₹214cr+20.0% on FY25
Capital spending: ₹173cr−19.0% on FY25
Free cash flow: ₹41.3cr−₹34.9 cr in FY25
Cash from financing: −₹29.0cr₹46.0 cr in FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Changes in working capital
Adjustments to reconcile profit — non-cash items						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	—	80.2	72.0	62.9	46.2
	—	14.6	14.8	16.1	0.0
	—	−13.3	−10.6	−14.0	−16.7
	—	0.0	0.0	−0.0	0.0
	—	3.0	3.9	0.0	−2.0
	—	0.6	−0.2	0.0	0.0
	—	0.0	0.0	0.0	16.5
	—	0.0	0.0	−4.9	0.4
	—	−10.5	64.2	−99.3	84.4
	—	−73.5	−39.0	27.7	−43.1
	—	0.0	0.0	162	0.0
	—	66.7	−46.1	0.0	−105
Cash from operating activities
	226	184	138	182	189
	—	67.8	59.0	150	−19.3
	—	252	197	332	169
	—	37.9	18.3	42.0	47.1
	—	214	179	290	122
Cash from investing activities
	—	173	214	274	212
	—	2.1	1.0	1.9	2.2
	—	0.0	0.0	0.5	17.6
	—	0.0	0.0	0.2	0.0
	—	11.6	12.3	13.5	17.7
	—	−38.8	46.1	67.9	89.5
	—	−198	−154	−191	−120
Cash from financing activities
	—	15.0	84.3	0.0	0.0
	—	0.0	0.0	46.9	−36.9
	—	0.0	0.0	0.2	1.1
	—	14.5	14.8	16.1	16.4
	—	29.4	23.5	29.4	23.5
	—	−0.1	0.0	0.0	0.0
	—	−29.0	46.0	−92.5	−4.1
	—	−12.8	70.5	6.3	−1.8
	—	−12.8	70.5	6.3	−1.8
	—	—	—	7.7	1.4
Reference items
	310	269	202	231	226
	12.3%	11.6%	9.7%	10.8%	10.2%
	41.3	41.3	−34.9	15.9	−89.6
	—	41.8	34.6	−47.1	—
	₹1.41	₹1.41	−₹1.19	₹0.54	−₹3.05
	128.29×	—	—	—	—
	—	1.56×	1.77×	2.16×	0.88×
	—	37.9	18.3	42.0	47.1
	—	14.5	14.8	16.1	16.4

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

IOLCP₹180.62

IOL Chemicals and Pharmaceuticals Limited

· Pharma & Health

₹ CrorePeersMOREPENLAB FDC INNOVACAP ORCHPHARMA SENORES SANOFI GUJTHEM RPGLIFEMcap ₹5,302 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation	46.2	62.9	72.0	80.2	—
+ Finance Costs	0.0	16.1	14.8	14.6	—
+ Interest Income	-16.7	-14.0	-10.6	-13.3	—
+ Fair Value (Gains) / Losses	0.0	-0.0	0.0	0.0	—
+ Unrealised FX (Gain) / Loss	-2.0	0.0	3.9	3.0	—
+ Other Non-cash Items	0.0	0.0	-0.2	0.6	—
+ Other — Cash Effects are Investing / Financing	16.5	0.0	0.0	0.0	—
+ Other Reconciling Items	0.4	-4.9	0.0	0.0	—
Changes in Working Capital
+ Inventories	84.4	-99.3	64.2	-10.5	—
+ Trade Receivables — Current	-43.1	27.7	-39.0	-73.5	—
+ Other Current Assets	0.0	162.0	0.0	0.0	—
+ Trade Payables — Current	-105.0	0.0	-46.1	66.7	—
Cash from Operating Activities
Profit Before Tax (per I/S)	188.7	181.7	138.0	184.4	225.5
+ Total Adjustments (incl. Working Capital)	-19.3	150.5	59.0	67.8	—
Cash from Operations (pre-tax)	169.4	332.1	196.9	252.2	—
+ Income Taxes Paid	47.1	42.0	18.3	37.9	—
Cash from Operating Activities	122.3	290.1	178.6	214.3	—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)	211.8	274.2	213.6	173.0	—
+ Disp of Fixed Assets	2.2	1.9	1.0	2.1	—
+ Acq of Investment Property	17.6	0.5	0.0	0.0	—
+ Disp of Investment Property	0.0	0.2	0.0	0.0	—
+ Interest Received — Investing	17.7	13.5	12.3	11.6	—
+ Other Inflows / (Outflows) — Investing	89.5	67.9	46.1	-38.8	—
Cash from Investing Activities	-120.0	-191.3	-154.2	-198.1	—
Cash from Financing Activities
+ Proceeds from Borrowings	0.0	0.0	84.3	15.0	—
+ Repayment of Borrowings	-36.9	46.9	0.0	0.0	—
+ Payment of Lease Liabilities	1.1	0.2	0.0	0.0	—
+ Interest Paid	16.4	16.1	14.8	14.5	—
+ Dividends Paid	23.5	29.4	23.5	29.4	—
+ Other Inflows / (Outflows) — Financing	0.0	0.0	0.0	-0.1	—
Cash from Financing Activities	-4.1	-92.5	46.0	-29.0	—
Net Changes in Cash (pre-FX)	-1.8	6.3	70.5	-12.8	—
Net Changes in Cash	-1.8	6.3	70.5	-12.8	—
Closing Cash	1.4	7.7	—	—	—
Reference Items
EBITDA	225.7	230.6	202.3	269.0	310.3
EBITDA Margin %	10.18	10.81	9.73	11.60	12.30
Free Cash Flow (CFO − Capex)	-89.6	15.9	-34.9	41.3	41.3
Free Cash Flow to Equity	—	-47.1	34.6	41.8	—
Free Cash Flow per Basic Share	-3.05	0.54	-1.19	1.41	1.41
Price to Free Cash Flow	—	—	—	—	128.29
Cash Flow to Net Income	0.88	2.16	1.77	1.56	—
Cash Paid for Taxes	47.1	42.0	18.3	37.9	—
Cash Paid for Interest	16.4	16.1	14.8	14.5	—

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.